HB Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.13M | Sell |
30,915
-3,537
| -10% | -$244K | 0.02% | 352 |
|
|
2025
Q1 | $2.39M | Buy |
34,452
+17,330
| +101% | +$1.2M | 0.02% | 342 |
|
|
2024
Q4 | $1.47M | Buy |
17,122
+875
| +5% | +$75.3K | 0.02% | 345 |
|
|
2024
Q3 | $1.93M | Buy |
16,247
+2,185
| +16% | +$260K | 0.02% | 280 |
|
|
2024
Q2 | $2.01M | Buy |
14,062
+355
| +3% | +$50.7K | 0.02% | 262 |
|
|
2024
Q1 | $1.76M | Buy |
13,707
+766
| +6% | +$98.4K | 0.02% | 270 |
|
|
2023
Q4 | $1.34M | Buy |
12,941
+3,145
| +32% | +$325K | 0.02% | 281 |
|
|
2023
Q3 | $891K | Buy |
9,796
+1,072
| +12% | +$97.5K | 0.01% | 315 |
|
|
2023
Q2 | $706K | Buy |
8,724
+690
| +9% | +$55.8K | 0.01% | 352 |
|
|
2023
Q1 | $639K | Sell |
8,034
-1,744
| -18% | -$139K | 0.01% | 364 |
|
|
2022
Q4 | $662K | Buy |
9,778
+2,066
| +27% | +$140K | 0.01% | 341 |
|
|
2022
Q3 | $384K | Buy |
7,712
+1,642
| +27% | +$81.8K | 0.01% | 391 |
|
|
2022
Q2 | $338K | Buy |
6,070
+1,096
| +22% | +$61K | 0.01% | 414 |
|
|
2022
Q1 | $276K | Buy |
+4,974
| New | +$276K | 0.01% | 470 |
|